TP53 and hepatocellular carcinoma: The p53 antigen has strong immunogenicity and spontaneously elicits immune responses, and the serum p53 antibody was reported to be positive in 32.9%, 15%, and 4.5% of patients with esophageal cancer, gastric cancer, and hepatocellular carcinoma, respectively.13